Clinical trials
Myasthenia Gravis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 10 |
| Not yet recruiting | 6 |
| Unknown status | 6 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ad scientiam | 2 |
| Hacettepe University | 2 |
| HealthPartners Institute | 2 |
| Massachusetts Eye and Ear Infirmary | 2 |
| University of Missouri-Columbia | 2 |
| Yi Ting Yeh | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing GoBroad Hospital | 1 |
| Beijing Tongren Hospital | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 47 |
| Thymoma | 5 |
| Stroke | 4 |
| Fatigue | 3 |
| Guillain-Barre Syndrome | 3 |
| Neuromuscular Diseases | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
| Autoimmune Diseases | 2 |
| Blepharoptosis | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.